SLC23A3

gene
On this page

Also known as SVCT3FLJ31168Yspl1

Summary

SLC23A3 (solute carrier family 23 member 3, HGNC:20601) is a protein-coding gene on chromosome 2q35, encoding Solute carrier family 23 member 3 (Q6PIS1). Acts as a sodium-dependent hypoxanthine transporter.

Predicted to enable transmembrane transporter activity. Involved in hypoxanthine transport. Predicted to be located in membrane.

Source: NCBI Gene 151295 — RefSeq curated summary.

At a glance

  • GWAS associations: 8
  • Clinical variants (ClinVar): 85 total
  • MANE Select transcript: NM_001144889

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:20601
Approved symbolSLC23A3
Namesolute carrier family 23 member 3
Location2q35
Locus typegene with protein product
StatusApproved
AliasesSVCT3, FLJ31168, Yspl1
Ensembl geneENSG00000213901
Ensembl biotypeprotein_coding
OMIM620339
Entrez151295

Gene structure

Transcript identifiers

Ensembl transcripts: 12 — 7 protein_coding, 3 retained_intron, 1 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined

ENST00000295738, ENST00000409370, ENST00000409878, ENST00000414999, ENST00000421779, ENST00000430764, ENST00000455516, ENST00000461812, ENST00000465580, ENST00000497918, ENST00000858810, ENST00000858811

RefSeq mRNA: 3 — MANE Select: NM_001144889 NM_001144889, NM_001144890, NM_144712

CCDS: CCDS42819, CCDS46517, CCDS46518

Canonical transcript exons

ENST00000409878 — 12 exons

ExonStartEnd
ENSE00001581895219165169219165422
ENSE00001828902219169823219170029
ENSE00003465693219169521219169678
ENSE00003489814219169309219169406
ENSE00003513185219162299219162394
ENSE00003536644219167930219168044
ENSE00003537893219163388219163555
ENSE00003539620219169029219169102
ENSE00003583612219164233219164338
ENSE00003635030219168195219168318
ENSE00003789532219168652219168833
ENSE00003899509219161465219162204

Expression profiles

Bgee: expression breadth ubiquitous, 170 present calls, max score 98.74.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1098 / max 63.2224, expressed in 14 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
340230.061611
340240.048212

Top tissues by expression

237 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
kidney epitheliumUBERON:000481998.74gold quality
ileal mucosaUBERON:000033198.05gold quality
mucosa of transverse colonUBERON:000499189.72gold quality
tibialis anteriorUBERON:000138586.90silver quality
adult mammalian kidneyUBERON:000008286.58gold quality
cortex of kidneyUBERON:000122586.21gold quality
kidneyUBERON:000211385.53gold quality
pancreatic ductal cellCL:000207984.79silver quality
lower esophagus mucosaUBERON:003583483.57gold quality
renal medullaUBERON:000036282.30gold quality
cardiac muscle of right atriumUBERON:000337981.55gold quality
left ventricle myocardiumUBERON:000656681.40gold quality
small intestine Peyer’s patchUBERON:000345481.37gold quality
small intestineUBERON:000210880.85gold quality
metanephros cortexUBERON:001053380.41gold quality
jejunal mucosaUBERON:000039980.34gold quality
duodenumUBERON:000211480.26gold quality
adult organismUBERON:000702379.63gold quality
upper arm skinUBERON:000426376.99gold quality
transverse colonUBERON:000115776.08gold quality
metanephrosUBERON:000008175.83gold quality
right coronary arteryUBERON:000162574.60gold quality
germinal epithelium of ovaryUBERON:000130474.56gold quality
epithelium of nasopharynxUBERON:000195174.46gold quality
jejunumUBERON:000211574.44gold quality
right lobe of liverUBERON:000111473.96gold quality
right lobe of thyroid glandUBERON:000111973.65gold quality
deltoidUBERON:000147673.63silver quality
gingival epitheliumUBERON:000194973.44gold quality
descending thoracic aortaUBERON:000234573.06gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-GEOD-99795no7.72
E-ANND-3no1.87

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

26 targeting SLC23A3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-450A-1-3P100.0069.331837
HSA-MIR-8485100.0077.574731
HSA-MIR-520D-5P99.9873.344883
HSA-MIR-524-5P99.9873.434882
HSA-MIR-4731-5P99.8967.232537
HSA-MIR-394199.8670.542735
HSA-MIR-3934-3P99.7665.511351
HSA-MIR-453099.6966.471509
HSA-MIR-1251-3P99.6467.211408
HSA-MIR-360999.5269.892587
HSA-MIR-548AH-5P99.5269.732626
HSA-MIR-216A-5P99.5068.021288
HSA-MIR-766-3P99.4765.241811
HSA-MIR-5589-3P99.2968.301443
HSA-MIR-4685-5P99.2565.991563
HSA-MIR-6837-5P99.2565.471632
HSA-MIR-5001-3P98.9167.281394
HSA-MIR-4712-3P98.5265.39822
HSA-MIR-338-3P98.1467.381137
HSA-MIR-4797-3P97.4867.14989
HSA-MIR-664B-5P96.7467.50509
HSA-MIR-339-5P96.7366.01820
HSA-MIR-125695.4466.33784
HSA-MIR-6753-5P94.7064.08470
HSA-MIR-1296-5P93.9467.71305
HSA-MIR-1537-3P90.5163.57105

Literature-anchored findings (GeneRIF, showing 2)

  • In the course of differentiation, the most pronounced changes in the expression levels were observed for the mRNAs that encode SLC30A10 and SLC23A3 transporters. Their increase correlated with an increase in the apical membrane area, indicating that SLC30A10 and SLC23A3 mRNA levels assessed by qRT-PCR may be employed as cell differentiation biomarkers in Caco-2 models. (PMID:30113032)
  • SLC23A3 is a renal hypoxanthine transporter. (PMID:35094660)

Cross-species orthologs

9 orthologs

OrganismSymbolGene ID
danio_rerioslc23a3ENSDARG00000088891
mus_musculusSlc23a3ENSMUSG00000026205
rattus_norvegicusSlc23a3ENSRNOG00000018266
caenorhabditis_elegansWBGENE00008252
caenorhabditis_elegansWBGENE00011593
caenorhabditis_elegansWBGENE00011595
caenorhabditis_elegansWBGENE00011596
caenorhabditis_elegansWBGENE00020004
caenorhabditis_elegansWBGENE00021994

Paralogs (2): SLC23A2 (ENSG00000089057), SLC23A1 (ENSG00000170482)

Protein

Protein identifiers

Solute carrier family 23 member 3Q6PIS1 (reviewed: Q6PIS1)

Alternative names: HPC E2-binding protein 3, Na(+)/L-ascorbic acid transporter 3, Sodium-dependent vitamin C transporter 3

All UniProt accessions (4): A0A0A0MSG3, C9JQ03, H7C2A2, Q6PIS1

UniProt curated annotations — full annotation on UniProt →

Function. Acts as a sodium-dependent hypoxanthine transporter. May show xanthine-hypoxanthine exchange activity.

Subcellular location. Membrane.

Similarity. Belongs to the nucleobase:cation symporter-2 (NCS2) (TC 2.A.40) family.

Isoforms (3)

UniProt IDNamesCanonical?
Q6PIS1-11yes
Q6PIS1-22
Q6PIS1-53

RefSeq proteins (3): NP_001138361, NP_001138362, NP_653313 (=MANE)

Domains & families (InterPro)

IDNameType
IPR006043NCS2Family

Pfam: PF00860

Catalyzed reactions (Rhea), 1 shown:

  • hypoxanthine(out) + Na(+)(out) = hypoxanthine(in) + Na(+)(in) (RHEA:76279)

UniProt features (35 total): topological domain 13, transmembrane region 12, compositionally biased region 3, region of interest 2, splice variant 2, sequence conflict 2, chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q6PIS1-F175.790.42

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 69 (showing top): HNF4_DR1_Q3, RYTAAWNNNTGAY_UNKNOWN, HNF4_01, PPAR_DR1_Q2, PPARA_01, GOBP_TRANSMEMBRANE_TRANSPORT, MARSON_BOUND_BY_FOXP3_UNSTIMULATED, WGTTNNNNNAAA_UNKNOWN, COUP_DR1_Q6, RASHI_RESPONSE_TO_IONIZING_RADIATION_1, GOMF_TRANSPORTER_ACTIVITY, MIKKELSEN_IPS_LCP_WITH_H3K27ME3, GOBP_NUCLEOBASE_TRANSPORT, SUPT16H_TARGET_GENES, MIR4731_5P

GO Biological Process (2): hypoxanthine transport (GO:0035344), transmembrane transport (GO:0055085)

GO Molecular Function (1): transmembrane transporter activity (GO:0022857)

GO Cellular Component (1): membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
purine nucleobase transport1
transport1
cellular process1
transporter activity1
transmembrane transport1
cellular anatomical structure1

Protein interactions and networks

STRING

498 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
SLC23A3SNRPFP62306505
SLC23A3RER1O15258478
SLC23A3CHPT1Q8WUD6470
SLC23A3SLC16A9Q7RTY1470
SLC23A3BCAS3Q9H6U6462
SLC23A3GSTA5Q7RTV2420
SLC23A3SLC17A4Q9Y2C5419
SLC23A3FDXACB1Q9BRP7404
SLC23A3RGS14O43566400
SLC23A3SLC5A9Q2M3M2380
SLC23A3MFSD11O43934377
SLC23A3TEX22C9J3V5370
SLC23A3CNPPD1Q9BV87368
SLC23A3SLC7A4O43246357
SLC23A3LRRC1Q9BTT6349

IntAct

4 interactions, top by confidence:

ABTypeScore
SLC23A3IGF1Rpsi-mi:“MI:0915”(physical association)0.400
SLC23A3PRODHpsi-mi:“MI:0915”(physical association)0.400
SLC23A3PGRMC2psi-mi:“MI:0914”(association)0.350

BioGRID (7): PRODH (Affinity Capture-MS), PRODH (Affinity Capture-MS), PGRMC2 (Affinity Capture-MS), RETSAT (Affinity Capture-MS), SSR1 (Affinity Capture-MS), SSR4 (Affinity Capture-MS), SLC23A3 (Affinity Capture-Western)

ESM2 similar proteins: A6NGC4, A6NKX4, A6NM10, F1NZP5, O96011, P0C242, P27544, P27545, Q0VCY6, Q2TBI8, Q3SYU3, Q4V8E5, Q5F2F2, Q5JZQ7, Q5RFI0, Q5U2T1, Q5U419, Q6AYM9, Q6GQT6, Q6PIS1, Q6TCG5, Q6UXD7, Q6UXT9, Q71RH2, Q7TNV1, Q7Z403, Q80ZE4, Q863Y8, Q86WI3, Q8BMT9, Q8CHK3, Q8IU68, Q8IXF9, Q8N9H8, Q8TBR7, Q8VC26, Q8WUG5, Q96N66, Q99640, Q99JT6

Diamond homologs: B0JZG0, O04472, P93039, Q0WPE9, Q27GI3, Q3E7D0, Q41760, Q60850, Q6PIS1, Q6SZ87, Q8GZD4, Q8RWE9, Q8VZQ5, Q94C70, Q9EPR4, Q9SHZ3, Q9UGH3, Q9UHI7, Q9WTW7, Q9WTW8, Q9Z2J0, A0A2A5JY22, O32139, O32140, P0AGM9, P0AGN0, P0AGN1, P0AGN2, P42086, P50487, P67444, P67445, P67446, Q46821, P45117, Q9CPL9, Q3E956

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

85 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance67
Likely benign5
Benign1

Top pathogenic / likely-pathogenic (0)

SpliceAI

2167 predictions. Top by Δscore:

VariantEffectΔscore
2:219163383:CCTA:Cdonor_loss1.0000
2:219163384:CTACC:Cdonor_loss1.0000
2:219163385:TAC:Tdonor_loss1.0000
2:219163386:A:ATdonor_loss1.0000
2:219163514:C:CTacceptor_gain1.0000
2:219163515:A:Tacceptor_gain1.0000
2:219162104:CA:Cdonor_gain0.9900
2:219162121:C:CAdonor_gain0.9900
2:219163381:CACCT:Cdonor_loss0.9900
2:219163382:ACCTA:Adonor_loss0.9900
2:219163385:TACC:Tdonor_loss0.9900
2:219163514:C:Tacceptor_gain0.9900
2:219163517:C:CTacceptor_gain0.9900
2:219163563:A:Cacceptor_gain0.9900
2:219163386:A:ACdonor_gain0.9800
2:219163387:C:CCdonor_gain0.9800
2:219163411:T:TAdonor_gain0.9800
2:219163556:C:CAacceptor_loss0.9800
2:219163557:T:Aacceptor_loss0.9800
2:219163563:A:ACacceptor_gain0.9800
2:219165418:CTCAC:Cacceptor_gain0.9800
2:219165420:CACCT:Cacceptor_loss0.9800
2:219165421:ACC:Aacceptor_loss0.9800
2:219165423:C:CAacceptor_loss0.9800
2:219165423:C:Tacceptor_loss0.9800
2:219165424:T:Aacceptor_loss0.9800
2:219168695:C:Adonor_gain0.9800
2:219161957:C:Adonor_gain0.9700
2:219162292:AACTT:Adonor_loss0.9700
2:219162293:ACTT:Adonor_loss0.9700

AlphaMissense

3857 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
2:219163470:A:CN453K0.973
2:219163470:A:TN453K0.973
2:219169373:G:CF118L0.964
2:219169373:G:TF118L0.964
2:219169375:A:GF118L0.964
2:219169571:G:CS90R0.962
2:219169571:G:TS90R0.962
2:219169573:T:GS90R0.962
2:219165377:C:TG320D0.956
2:219165202:G:CS378R0.950
2:219165202:G:TS378R0.950
2:219165204:T:GS378R0.950
2:219165378:C:GG320R0.946
2:219165247:A:CS363R0.940
2:219165247:A:TS363R0.940
2:219165249:T:GS363R0.940
2:219168808:C:TG173E0.938
2:219162313:T:AE508V0.936
2:219169523:G:CS106R0.936
2:219169523:G:TS106R0.936
2:219169525:T:GS106R0.936
2:219169557:C:TG95D0.932
2:219163513:C:TG439E0.917
2:219165223:G:CS371R0.917
2:219165223:G:TS371R0.917
2:219165225:T:GS371R0.917
2:219168809:C:GG173R0.917
2:219168809:C:TG173R0.917
2:219163443:G:CF462L0.915
2:219163443:G:TF462L0.915

dbSNP variants (sampled 300 via entrez): RS1000036236 (2:219161146 C>T), RS1000053654 (2:219162936 A>G,T), RS1000653064 (2:219164177 C>G,T), RS1001454482 (2:219169581 A>G), RS1001567573 (2:219170039 G>A), RS1001784899 (2:219171194 T>C), RS1002056794 (2:219165544 C>G,T), RS1002111016 (2:219162708 A>G), RS1002415404 (2:219164047 G>C), RS1002655110 (2:219167268 TTAAA>T,TTAAATAAA), RS1003691376 (2:219165453 C>T), RS1003782567 (2:219162791 G>A), RS1003835007 (2:219162530 C>G), RS1004054723 (2:219167730 A>G), RS1004130531 (2:219165798 C>G,T)

Disease associations

OMIM: gene MIM:620339 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

8 associations (top):

StudyTraitp-value
GCST000175_19Height1.000000e-06
GCST002702_34Height1.000000e-11
GCST008163_280Height1.000000e-06
GCST011816_2Vitamin C levels2.000000e-30
GCST012226_195Waist circumference adjusted for body mass index5.000000e-08
GCST012226_197Waist circumference adjusted for body mass index2.000000e-10
GCST90002392_175Mean corpuscular volume2.000000e-09
GCST90020028_715Hip circumference adjusted for BMI1.000000e-08

EFO canonical traits (3, from GWAS)

EFO IDTrait name
EFO:0600003vitamin C measurement
EFO:0007789BMI-adjusted waist circumference
EFO:0008039BMI-adjusted hip circumference

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

GtoPdb / IUPHAR curated pharmacology

(IUPHAR/BPS Guide to Pharmacology — expert-curated)

Target class: transporter — SLC23 family of ascorbic acid transporters

CTD chemical–gene interactions

23 total (human), top 23 by PubMed support.

ChemicalActions (top 5)PubMed papers
Tetrachlorodibenzodioxinaffects expression2
aristolochic acid Iincreases expression1
methylmercuric chlorideincreases expression1
propionaldehydeincreases expression1
2,5,2’,5’-tetrachlorobiphenyldecreases expression1
tris(2-butoxyethyl) phosphateaffects expression1
sodium arsenitedecreases expression1
di-n-butylphosphoric acidaffects expression1
CGP 52608increases reaction, affects binding1
jinfukangaffects cotreatment, decreases expression1
2,3,5-trichloro-6-phenyl-(1,4)benzoquinonedecreases expression1
Arbutinincreases expression1
Benzo(a)pyreneincreases methylation1
Cadmiumdecreases expression, increases abundance1
Cisplatindecreases expression, affects cotreatment1
Hydralazineaffects cotreatment, increases expression1
Rifampindecreases expression1
Smokedecreases expression1
Tobacco Smoke Pollutionincreases expression1
Urethaneincreases expression1
Valproic Acidaffects cotreatment, increases expression1
Cadmium Chloridedecreases expression, increases abundance1
S-Nitrosoglutathionedecreases expression1

Cellosaurus cell lines

2 cell lines: 2 cancer cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_D4EQ1321N1-SLC23A3-KO-c6Cancer cell lineMale
CVCL_D4ER1321N1-SLC23A3-KO-c7Cancer cell lineMale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.